{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:12:22Z","timestamp":1769213542423,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Journal Armed Forces India"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.mjafi.2018.12.013","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T02:09:35Z","timestamp":1547777375000},"page":"18-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Current trends in tuberculosis vaccine"],"prefix":"10.1016","volume":"75","author":[{"given":"J.S.V.","family":"Soundarya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uma Devi","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srikanth P.","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mjafi.2018.12.013_bib1","series-title":"WHO Global Tuberculosis Report","year":"2018"},{"issue":"4","key":"10.1016\/j.mjafi.2018.12.013_bib2","first-page":"27","article-title":"WHO position paper","volume":"79","author":"WHO BCG vaccine","year":"2004","journal-title":"Wkly Epidemiol Rec"},{"issue":"JUN","key":"10.1016\/j.mjafi.2018.12.013_bib3","article-title":"Bacille Calmette-Guerin complications in newly described primary immunodeficiency diseases: 2010-2017","volume":"9","author":"Nunes-Santos","year":"2018","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.mjafi.2018.12.013_bib4","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/IAI.73.2.1196-1203.2005","article-title":"Long-term protection against tuberculosis following vaccination with a severely attenuated double lysine and pantothenate auxotroph of Mycobacterium tuberculosis","volume":"73","author":"Sambandamurthy","year":"2005","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.mjafi.2018.12.013_bib5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1357-4310(99)01594-4","article-title":"Beyond BCG: The potential for a more effective TB vaccine","volume":"5","author":"Orme","year":"1999","journal-title":"Mol Med Today"},{"issue":"4","key":"10.1016\/j.mjafi.2018.12.013_bib6","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s12052-011-0365-y","article-title":"The Double-Edged Sword: How evolution can make or break a live-attenuated virus vaccine","volume":"4","author":"Hanley","year":"2011","journal-title":"Evol Educ Outreach"},{"issue":"1","key":"10.1016\/j.mjafi.2018.12.013_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.vaccine.2009.09.087","article-title":"Recombinant Proapoptotic M. tuberculosis Generates CD8+ T-cell Responses Against Human Immunodeficiency Virus Type 1 Env and M. tuberculosis in Neonatal Mice","volume":"28","author":"Ranganathan","year":"2010","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.mjafi.2018.12.013_bib8","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1128\/CVI.00184-12","article-title":"A recombinant attenuated Mycobacterium tuberculosis vaccine strain is safe in immunosuppressed simian immunodeficiency virus-infected infant macaques","volume":"19","author":"Jensen","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.mjafi.2018.12.013_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0117242","article-title":"Targeting of non-dominant antigens as a vaccine strategy to broaden T-cell responses during chronic viral infection","volume":"10","author":"Holst","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.mjafi.2018.12.013_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nm.4473","article-title":"Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine","volume":"24","author":"Hansen","year":"2018","journal-title":"Nat Med"},{"issue":"FEB","key":"10.1016\/j.mjafi.2018.12.013_bib11","article-title":"Dendritic cell targeting effectively boosts T cell responses elicited by an HIV multiepitope DNA vaccine","volume":"8","author":"Apost\u00f3lico","year":"2017","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.mjafi.2018.12.013_bib12","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.molimm.2004.09.034","article-title":"Single chain antibody fragments for the selective targeting of antigens to dendritic cells","volume":"42","author":"Demangel","year":"2005","journal-title":"Mol Immunol"},{"issue":"7607","key":"10.1016\/j.mjafi.2018.12.013_bib13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mjafi.2018.12.013_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1128\/CVI.00718-14","article-title":"Tuberculosis vaccine types and timings","volume":"22","author":"Orme","year":"2015","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"10.1016\/j.mjafi.2018.12.013_bib15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1586\/erv.11.28","article-title":"Tuberculosis vaccines in clinical trials","volume":"10","author":"Rowland","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.mjafi.2018.12.013_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/72413","article-title":"Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines","volume":"7","author":"Ronning","year":"2000","journal-title":"Nat Struct Biol"},{"issue":"10","key":"10.1016\/j.mjafi.2018.12.013_bib17","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.4049\/jimmunol.173.10.6357","article-title":"Single Mucosal, but Not Parenteral, Immunization with Recombinant Adenoviral-Based Vaccine Provides Potent Protection from Pulmonary Tuberculosis","volume":"173","author":"Wang","year":"2004","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.mjafi.2018.12.013_bib18","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1586\/14760584.2013.856765","article-title":"Recent developments in tuberculosis vaccines","volume":"12","author":"M","year":"2013","journal-title":"Expert Rev Vaccines"},{"issue":"10","key":"10.1016\/j.mjafi.2018.12.013_bib19","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(14)70845-X","article-title":"Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: A phase 1, double-blind, randomised controlled trial","volume":"14","author":"Satti","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.mjafi.2018.12.013_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/thoraxjnl-2014-205202","article-title":"TB vaccine development: Where are we and why is it so difficult?","volume":"70","author":"Wilkie","year":"2015","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.mjafi.2018.12.013_bib21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.qco.0000168380.08895.9a","article-title":"Recent developments in Tuberculosis vaccines","volume":"18","author":"Haile","year":"2005","journal-title":"Curr Opin Infect Dis"},{"issue":"DEC","key":"10.1016\/j.mjafi.2018.12.013_bib22","first-page":"1","article-title":"MTBVAC: Attenuating the human pathogen of tuberculosis (TB) toward a promising vaccine against the TB epidemic","volume":"8","author":"Gonzalo-Asensio","year":"2017","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.mjafi.2018.12.013_bib23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/infdis\/jix030","article-title":"Revaccination of Guinea pigs with the live attenuated Mycobacterium tuberculosis vaccine MTBVAC improves BCG's protection against tuberculosis","volume":"216","author":"Clark","year":"2017","journal-title":"J Infect Dis"},{"issue":"26","key":"10.1016\/j.mjafi.2018.12.013_bib24","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.vaccine.2016.02.074","article-title":"Status of vaccine research and development of vaccines for HIV-1","volume":"34","author":"Safrit","year":"2016","journal-title":"Vaccine"},{"issue":"3-4 SPEC. ISS.","key":"10.1016\/j.mjafi.2018.12.013_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tube.2006.01.024","article-title":"RUTI: A new chance to shorten the treatment of latent tuberculosis infection","volume":"86","author":"Cardona","year":"2006","journal-title":"Tuberculosis"},{"issue":"5","key":"10.1016\/j.mjafi.2018.12.013_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1371\/journal.pone.0020404","article-title":"Prophylactic effect of a therapeutic vaccine against tb based on fragments of mycobacterium tuberculosis","volume":"6","author":"Vilaplana","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.mjafi.2018.12.013_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S2213-2600(18)30077-8","article-title":"Safety and immunogenicity of the novel tuberculosis vaccine ID93\u2008+\u2008GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial","volume":"6","author":"Penn-Nicholson","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.mjafi.2018.12.013_bib28","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1080\/21645515.2015.1120393","article-title":"Current status of new tuberculosis vaccine in children","volume":"12","author":"Pang","year":"2016","journal-title":"Hum Vaccines Immunother"},{"issue":"20","key":"10.1016\/j.mjafi.2018.12.013_bib29","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1016\/j.vaccine.2010.02.094","article-title":"Ag85B-ESAT-6 adjuvanted with IC31\u00ae promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in na\u00efve human volunteers","volume":"28","author":"van Dissel","year":"2010","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.mjafi.2018.12.013_bib30","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1016\/j.vaccine.2006.03.072","article-title":"Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31","volume":"24","author":"Agger","year":"2006","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.mjafi.2018.12.013_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0003683","article-title":"Adult-like anti-mycobacterial T cell and in\u00a0vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31\u00ae adjuvant","volume":"3","author":"Kamath","year":"2008","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.mjafi.2018.12.013_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0168521","article-title":"Immunogenicity and protective efficacy of the DAR-901 booster vaccine in a murine model of tuberculosis","volume":"11","author":"Lahey","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.mjafi.2018.12.013_bib33","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/0141076817732965","article-title":"Correcting the record on BCG before we license new vaccines against tuberculosis","volume":"110","author":"von Reyn","year":"2017","journal-title":"J R Soc Med"},{"key":"10.1016\/j.mjafi.2018.12.013_bib34","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b Controlled Trial of M72\/AS01E Vaccine to Prevent Tuberculosis","volume":"379","author":"Van Der Meeren","year":"2018","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.mjafi.2018.12.013_bib35","first-page":"1","article-title":"Vaccine against tuberculosis: What's new?","volume":"14","author":"Montagnani","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.mjafi.2018.12.013_bib36","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/QAD.0b013e3283350f1b","article-title":"Prevention of tuberculosis in Bacille Calmette-Gu\u00e9rin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine","volume":"24","author":"Von Reyn","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.mjafi.2018.12.013_bib37","article-title":"Vaccines-Recent advances and clinical trials","author":"Marisol Ocampo","year":"2015","journal-title":"Book"},{"issue":"1","key":"10.1016\/j.mjafi.2018.12.013_bib38","first-page":"1","article-title":"Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trial","volume":"7","author":"Sharma","year":"2017","journal-title":"Sci Rep"}],"container-title":["Medical Journal Armed Forces India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123718301734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123718301734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T11:48:06Z","timestamp":1759837686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0377123718301734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0377123718301734"],"URL":"https:\/\/doi.org\/10.1016\/j.mjafi.2018.12.013","relation":{},"ISSN":["0377-1237"],"issn-type":[{"value":"0377-1237","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current trends in tuberculosis vaccine","name":"articletitle","label":"Article Title"},{"value":"Medical Journal Armed Forces India","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mjafi.2018.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Armed Forces Medical Services (AFMS).","name":"copyright","label":"Copyright"}]}}